Synergy Pharmaceuticals is Drug Discovery in United States that focus on Synergy Pharmaceuticals Inc functions business. They cover business area such as Synergy Pharmaceuticals Inc function, develop therapy, gastrointestinal disease, its product, candidate, plecanatide, dolcanatide, Plecanatide, chronic idiopathic constipation, Dolcanatide, inflammatory bowel disease, digestive breakdown.
-
Synergy Pharmaceuticals Inc Functions
-
420 Lexington Avenue
Suite 2012
New York, NY 10170
United States
Private
Synergy Pharmaceuticals Inc functiondevelop therapygastrointestinal diseaseits productcandidateplecanatidedolcanatidePlecanatidechronic idiopathic constipationDolcanatideinflammatory bowel diseasedigestive breakdown
* We use standard office opening hours in near Synergy Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Synergy Pharmaceuticals is Drug Discovery business from United States that founded in - ( years old in ), Synergy Pharmaceuticals business is focusing on Synergy Pharmaceuticals Inc Functions.
Synergy Pharmaceuticals headquarter office and corporate office address is located in 420 Lexington Avenue Suite 2012 New York, NY 10170 United States.
Synergy Pharmaceuticals was founded in United States.
In , Synergy Pharmaceuticals is currently focus on Synergy Pharmaceuticals Inc functions sector.
Above is snippet of Google Trends for "Synergy Pharmaceuticals Inc functions" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Synergy Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
